Catalyst Wire Dossier Catalyst Wire Dossier

Sycrest

asenapine maleate · Organon N.V.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sycrest, covering 2018-07-31 to 2026-02-25. Get the full timeline:

Most recent: EMA Authorised: Sycrest (asenapine maleate) — Organon N.V.

See pricing